Sign in

NCT06079970Recruiting

Confocal Laser Endomicroscopy VERification

Bronchoscopy With and Without Needle-based Confocal Laser Endomicroscopy for Peripheral Lung Nodule Diagnosis: Protocol for a Multicenter Randomized Controlled Trial (CLEVER Trial)

Source: ClinicalTrials.gov · Last updated 7 Apr 2026

Brief summary (registry, in English)

The goal of this multi-center randomized clinical trial is to evaluate the added value of needle based confocal laser endomicroscopy (nCLE)-imaging to regular diagnostic bronchoscopic peripheral lung lesion analysis on the diagnostic yield in patients with peripheral pulmonary nodules suspect for malignancy. The main question\[s\] it aims to answer are: To determine if the addition of nCLE-imaging to conventional diagnostic bronchoscopic peripheral lung lesion analysis results in an improved diagnostic yield (defined as the proportion of patients in whom the bronchoscopic procedure results in a definitive diagnosis out of the total number of patients that have received the diagnostic bronchoscopic procedure). Participants will undergo diagnostic bronchoscopy either with or without the addition of nCLE imaging before each TBNA. Based on the feedback of the CLE images on (in)correct placement of the needle, the needle might be repositioned before sampling. Comparison between the diagnostic yield of these groups will be done including subgroup analysis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
208 (estimated)
First submitted
2 Oct 2023
Start date
18 Oct 2023
Primary completion date
31 Dec 2026
Lead sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Diseases
Lung cancer
NCT number
NCT06079970

What you commit to

  • Study type: Interventional
  • Planned participants: 208
  • From 18 Oct 2023 to the primary completion date, 31 Dec 2026
  • 5 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Undergoing chemotherapy as several chemotherapies have fluorescent properties at the same wavelength (e.g., doxorubicin)

Other illness

  • Endobronchial visible malignancy on bronchoscopic inspection
  • Failure to comply with the study protocol
  • Known allergy or risk factors for an allergic reaction to fluorescein

Other

  • Inability or non-willingness to provide informed consent
  • Target lesion within reach of the linear EBUS scope
  • Pregnancy or breastfeeding
  • Hemodynamic instability
  • Refractory hypoxemia
  • Therapeutic anticoagulant use that cannot be withheld for an appropriate interval before the procedure
  • Unable to tolerate general anesthesia according to the anesthesiologist

Who the study is looking for

  • ≥18 years of age
  • Suspected malignant peripheral lung lesion with an indication for a bronchoscopic diagnostic work-up as determined by the attending physician or tumor board. Peripheral pulmonary lesions are defined as lesions located beyond the visible segmental bronchi, not detectable by regular flexible bronchoscopy
  • Bronchus sign on pre-procedural CT or estimated confidence for successful navigation to the nodule resulting in a r-EBUS signal
  • Solid part of the lesion must be ≧10 mm
  • Largest dimension of lesion size on CT ≦30 mm (long-axis)
  • Ability to understand and willingness to sign a written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Vienna General Hospital
Coordinator of this site? Confirm its status
ViennaAustriaRecruiting
General University Hospital Prague
Coordinator of this site? Confirm its status
PragueCzechiaRecruiting
Sotiria Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Amsterdam University Medical Centers
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
Montefiore Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.